Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,236 | N/A | N/A |
| Marketable Securities | 266 | N/A | N/A |
| Receivables | 1,912 | N/A | N/A |
| Other current assets | 291 | 0 | 0 |
| TOTAL | $3,999 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 602 | N/A | N/A |
| Intangibles | 1,140 | 0 | 0 |
| Other Non-Current Assets | 7,132 | 0 | 0 |
| TOTAL | $8,874 | $N/A | $N/A |
| Total Assets | $12,873 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 247 | N/A | N/A |
| Accounts payable and accrued liabilities | 360 | 0 | 0 |
| Accrued Expenses | 667 | N/A | N/A |
| Other current liabilities | 1,402 | N/A | N/A |
| TOTAL | $7,342 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 122 | N/A | N/A |
| Deferred Revenues | 4,251 | N/A | N/A |
| Other Non-Current Liabilities | 4,967 | 0 | 0 |
| TOTAL | $5,089 | $N/A | $N/A |
| Total Liabilities | $12,431 | $N/A | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | N/A | 9,829 | N/A |
| Common Shares | 1,019 | N/A | N/A |
| Retained earnings | -22,872 | N/A | N/A |
| Other shareholders' equity | -367 | 0 | 0 |
| TOTAL | $442 | $N/A | $N/A |
| Total Liabilities And Equity | $12,873 | $0 | $0 |